Nano Medicine and Nano Safety
portes grátis
Nano Medicine and Nano Safety
Recent Trends and Clinical Evidences
Das, Malay K.; Pathak, Yashwant V.
Springer Verlag, Singapore
12/2021
635
Mole
Inglês
9789811562570
15 a 20 dias
1153
Descrição não disponível.
Chapter 1_Applications of Nano Biotechnology in the development of Nano Medicine.- Chapter 1.1. Nano biotechnology and its application in Nano medicine:An Overview.- Chapter 1.2. Nano biotechnology for therapeutic targeting of circulating tumor cells in the blood.-Chapter 1.3. Application of Nano biotechnology in clinical diagnosis.- Chapter 1.4. Anti-diabetic Nano formulation from herbal source.- Chapter 1.5. Nano materials for alternative antibiotic therapy.- Chapter 2. Nano Medicine: concept, development, clinical applications and evidences.- Chapter 2.1. Nano medicines and Nanodelivery systems: trends and perspectives.- Chapter 2.2. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications.- Chapter 2.3. Nano medicines: Products on the market and in the pipeline.- Chapter 2.4. Transdermal Nano medicines for enhanced dose control and tissue targeting.- Chapter 2.5. Multifunctional mesoporous silica nanoparticles for biomedical applications.- Chapter 2.6. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases.- Chapter 2.7. Functionalized lipid-polymer hybrid nanoparticles for cancer targeted chemotherapy.- Chapter 2.8. Lipid-polymer hybrid nanoparticle based Nano medicine for enhanced management of psoriasis.- Chapter 2.9. Nano medicines for gene therapy.- Chapter 2.10. Herbal Nano medicines for cancer chemotherapy.- Chapter 2.11. pH-responsive nanomaterials for cancer diagnosis and treatment.- Chapter 2.12. Stimuli-responsive polymers for cancer Nano medicines.- Chapter 2.13. Nano medicine for challenging cancers such as pancreas and other relatively inaccessible organs.- Chapter 2.14. Targeting Nano medicines to bone metastasis and cancer stem cells.- Chapter 2.15. Clinical impact of Nano sized extracellular vesicles for theranostic areas of Nanomedicines.- Chapter 2.16. Multifunctional Nano scale particles for theranostic application in healthcare.- Chapter 2.17. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy.- Chapter 3. Regulatory, safety and marketing aspects of Nano Medicine.- Chapter 3.1. Nano toxicity and risk-benefit assessment of Nano medicines.- Chapter 3.2. Risk assessment and risk management guidance of Nano medicines inoccupational safety and health.- Chapter 3.3. Clinical toxicities of Nano medicines.- Chapter 3.4. Public health concerns related to Nano medicines.- Chapter 3.5. Wait and watch: Regulatory approaches to Nano medicines.- Chapter 3.6. Global growth of Nano medicines and what role it will play for economically weak countries.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Nanomedicines;Nano drug delivery systems;Theranostic nanoparticles;Herbal nanomedicines;Transdermal nanomedicines;Multifunctional mesoporous silica nanoparticles
Chapter 1_Applications of Nano Biotechnology in the development of Nano Medicine.- Chapter 1.1. Nano biotechnology and its application in Nano medicine:An Overview.- Chapter 1.2. Nano biotechnology for therapeutic targeting of circulating tumor cells in the blood.-Chapter 1.3. Application of Nano biotechnology in clinical diagnosis.- Chapter 1.4. Anti-diabetic Nano formulation from herbal source.- Chapter 1.5. Nano materials for alternative antibiotic therapy.- Chapter 2. Nano Medicine: concept, development, clinical applications and evidences.- Chapter 2.1. Nano medicines and Nanodelivery systems: trends and perspectives.- Chapter 2.2. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications.- Chapter 2.3. Nano medicines: Products on the market and in the pipeline.- Chapter 2.4. Transdermal Nano medicines for enhanced dose control and tissue targeting.- Chapter 2.5. Multifunctional mesoporous silica nanoparticles for biomedical applications.- Chapter 2.6. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases.- Chapter 2.7. Functionalized lipid-polymer hybrid nanoparticles for cancer targeted chemotherapy.- Chapter 2.8. Lipid-polymer hybrid nanoparticle based Nano medicine for enhanced management of psoriasis.- Chapter 2.9. Nano medicines for gene therapy.- Chapter 2.10. Herbal Nano medicines for cancer chemotherapy.- Chapter 2.11. pH-responsive nanomaterials for cancer diagnosis and treatment.- Chapter 2.12. Stimuli-responsive polymers for cancer Nano medicines.- Chapter 2.13. Nano medicine for challenging cancers such as pancreas and other relatively inaccessible organs.- Chapter 2.14. Targeting Nano medicines to bone metastasis and cancer stem cells.- Chapter 2.15. Clinical impact of Nano sized extracellular vesicles for theranostic areas of Nanomedicines.- Chapter 2.16. Multifunctional Nano scale particles for theranostic application in healthcare.- Chapter 2.17. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy.- Chapter 3. Regulatory, safety and marketing aspects of Nano Medicine.- Chapter 3.1. Nano toxicity and risk-benefit assessment of Nano medicines.- Chapter 3.2. Risk assessment and risk management guidance of Nano medicines inoccupational safety and health.- Chapter 3.3. Clinical toxicities of Nano medicines.- Chapter 3.4. Public health concerns related to Nano medicines.- Chapter 3.5. Wait and watch: Regulatory approaches to Nano medicines.- Chapter 3.6. Global growth of Nano medicines and what role it will play for economically weak countries.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
